间充质干细胞端粒酶催化亚基RT-qPCR方法的建立&#x0002A;

陈晓菲; 李慧婷; 董莹莹; 曹译丹; 付欣悦; 刘明月; 张瑞瑞; 王艳辉; 王新乐; 崔梦姗; 张峒; 庞琳; 饶春明

doi:10.16155/j.0254-1793.2024-1333

药物分析杂志 >

2025 , Vol. 45 >Issue 1: 20 - 29

DOI: https://doi.org/10.16155/j.0254-1793.2024-1333

干细胞产品质量研究与检测专栏

间充质干细胞端粒酶催化亚基RT-qPCR方法的建立^*

陈晓菲 ,
李慧婷 ,
董莹莹 ,
曹译丹 ,
付欣悦 ,
刘明月 ,
张瑞瑞 ,
王艳辉 ,
王新乐 ,
崔梦姗 ,
张峒 ,
庞琳 ,
饶春明

展开

北京昭衍药物检定研究有限公司,北京 102605

第一作者 Tel：（010）67869966；E-mail：chenxiaofei@joinn-lab.com

**饶春明 Tel：（010）67869966;E-mail：raochunming@joinn-lab.com
庞琳 Tel：（010）67869966;E-mail：panglin@joinn-lab.com

收稿日期: 2024-12-12

网络出版日期: 2025-05-29

基金资助

*北京市科技计划课题：基因修饰免疫细胞和基因治疗药物质量控制关键技术与服务平台建设（Z221100007922015）

收起

Establishment of RT-qPCR method for telomerase catalytic subunits of mesenchymal stem cells^*

CHEN Xiao-fei ,
LI Hui-ting ,
DONG Ying-ying ,
CAO Yi-dan ,
FU Xin-yue ,
LIU Ming-yue ,
ZHANG Rui-rui ,
WANG Yan-hui ,
WANG Xin-yue ,
CUI Meng-shan ,
ZHANG Tong ,
PANG Lin ,
RAO Chun-ming

Expand

JOINN pharmaceutical Quality Research and Testing(Beijing)Co., Ltd., Beijing 102605, China

Received date: 2024-12-12

Online published: 2025-05-29

Fold

摘要

目的: 建立一种简便、高效的端粒酶活性检测方法,用于评价间充质干细胞产品的成瘤性风险。方法: 针对端粒酶催化亚基（TERT）的保守结构域设计特异性引物和探针,并对TERT基因的引物和探针进行优化筛选,同时设置内参基因的引物和探针,在一个反应体系内使用双色荧光探针进行多重定量PCR反应,建立RT-qPCR探针法。应用该法对人间充质干细胞中是否表达TERT基因来间接判断细胞中是否存在端粒酶活性。结果: 该方法可稳定特异地检测到阳性对照细胞293T/17的TERT基因,Ct平均值为23.96,RSD为1.5%。内参基因GAPDH均可以正常检出,Ct平均值为14.13,RSD为1.3%。阴性对照细胞MRC-5内参基因GAPDH可以正常检出,Ct平均值为12.81,RSD为0.46%,TERT基因未检出,该细胞端粒酶活性为阴性。人间充质干细胞HMSC内参基因GAPDH可以正常检出,Ct平均值为13.01,RSD为3.8%,TERT基因未检出,人间充质干细胞HMSC的端粒酶活性为阴性。结论: 本研究建立的RT-qPCR探针法重复性好,特异性高,能够准确检测端粒酶阳性细胞催化亚基mRNA的转录。可用于间充质干细胞的端粒酶活性分析,间接评估间充质干细胞成瘤性风险。

关键词： 荧光定量RT-PCR探针法; 端粒酶催化亚基; 端粒酶活性; 干细胞; 成瘤性

本文引用格式

陈晓菲 , 李慧婷 , 董莹莹 , 曹译丹 , 付欣悦 , 刘明月 , 张瑞瑞 , 王艳辉 , 王新乐 , 崔梦姗 , 张峒 , 庞琳 , 饶春明 . 间充质干细胞端粒酶催化亚基RT-qPCR方法的建立^*[J]. 药物分析杂志, 2025 , 45(1) : 20 -29 . DOI: 10.16155/j.0254-1793.2024-1333

Abstract

Objective: To establish a simple and efficient method for detecting telomerase activity for evaluating tumorigenic risk of cell products. Methods: Specific primers and probes were designed for the conserved domain of telomerase catalytic subunit (TERT), and the primers and probes of TERT gene were optimized and screened, and the primers and probes of internal reference genes were set up. Multiple quantitative PCR reaction was performed using two-color fluorescent probes in a reaction system, and RT-qPCR probe method was established. The expression of TERT gene in human mesenchymal stem cells HMSC was used to determine whether telomerase activity existed in the cells indirectly. Results: TERT gene of 293T/17 positive control cells could be stably and specifically detected by this method, with a mean Ct value of 23.96 and a RSD of 1.5. The internal reference gene GAPDH could be detected successfully, the mean Ct value was 14.13, the RSD was 1.3%. The reference gene GAPDH in MRC-5 could be detected in negative control cells, the mean Ct value was 12.81, the RSD was 0.46%, the TERT gene was not detected, and the telomerase activity was negative. The reference gene GAPDH in HMSC could be detected, the Ct mean value was 13.01, and the RSD was 3.8%, whereas, the telomerase activity of HMSC was negative. Conclusion: The real-time fluorescent quantitative RT-qPCR probe method established in this study can accurately detect the expression of catalytic subunit mRNA in telomerase positive cells with good repeatability and high specificity. It can be used to analyze telomerase activity of stem cells and indirectly evaluate tumorigenic risk of cell products derived from stem cells.

Key words： fluorescent quantitative RT-PCR probe method; telomerase reverse transcriptase; telomerase activity; stem cell; tumorigenicity

参考文献

[1] ZHANG X, LOU X, XIA F.Advances in the detection of telomerase activity using isothermal amplification[J]. Theranostics, 2017, 7(7): 1847
[2] BLACKBURN EH.Structure and function of telomeres[J]. Nature, 1991, 350(6319): 569
[3] HOLT SE, SHAY JW.Role of telomerase in cellular proliferation and cancer[J]. J Cell Physiol, 1999, 180(1): 10
[4] SMITH EM, PENDLEBURY DF, NANDAKUMAR J.Structural biology of telomeres and telomerase[J]. Cell Mol Life Sci, 2020, 77(1): 61
[5] SHAY JW, WRIGHT WE.Role of telomeres and telomerase in cancer[J]. Semin Cancer Biol, 2010,21(6):349
[6] HONG B, ZU Y.Detecting circulating tumor cells: current challenges and new trends[J]. Theranostics, 2013, 3(6): 377
[7] 国家药品监督管理局药品审评中心. 人源干细胞产品药学研究与评价技术指导原则(试行)[EB/OL]. (2023-04-27)[2024-11-28]. https://www.cde.org.cn/main/news/viewInfoCommon/1dfacaa7804aca84d648edb83b10c40b
NMPA. Technical Guidelines for Pharmaceutical Research and Evaluation of Human Stem Cell Products (Trial)[EB/OL]. (2023-04-27)[2024-11-28]. https://www.cde.org.cn/main/news/viewInfoCommon/1dfacaa7804aca84d648edb83b10c40b
[8] 国家药品监督管理局药品审评中心.人源干细胞及衍生细胞治疗产品临床技术指导原则(试行)[EB/OL]. (2023-06-26) https://www.cde.org.cn/main/news/viewInfoCommon/1dfacaa7804aca84d648edb83b10c40b
NMPA.Clinical Guidelines for Human Stem Cells and Derived Cell Therapy Products (Trial)[EB/OL]. (2023-06-26) https://www.cde.org.cn/main/news/viewInfoCommon/1dfacaa7804aca84d648edb83b10c40b
[9] 龚光明,秦洁,陈宗德,等. 干细胞的端粒酶活性研究进展[J]. 医学综述,2004,10(2): 78
GONG GM, QIN J, CHEN ZD, et al.Research progress on telomerase activity of stem cells[J]. Med Recapit, 2004, 10(2): 78
[10] 张彦,冯哲玲,熊建军,等. 淋巴母细胞端粒酶活性和成瘤性的关系[J]. 分子诊断与治疗杂志,2010,2(3): 156
ZHANG Y, FENG ZL, XIONG JJ, et al.The relationship of telomerase activity and tumorigenesis of lymphoblastoid cell lines[J]. J Mol Diagn Ther, 2010, 2(3): 156
[11] NINGARHARI M, GARUSO S, HIRSCH TZ, et al.Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target[J]. J Hepatol, 2020, 74(5): 1155
[12] 张敏,奚耕思,周艳妮. 端粒酶活性检测的几种方法[J]. 细胞生物学杂志,2004,26(1): 68
ZHANG M, XI GS, ZHOU YN.Detection methods for telomerase activity[J]. Chin J Cell Biol, 2004, 26(1): 68
[13] KIM NW, PIATYSZEK MA, PROWSE KR, et al.Specific association of human telomerase activity with immortal cells and cancer[J]. Science, 1994, 266(5193): 2011
[14] WISMAN GBA, HOLLEMA H, HELDER MN, et al.Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours[J]. Int J Oncol, 2003, 23(5): 1451
[15] SHENG WY, CHIEN YL, WANG TCV.The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes[J]. FEBS Letters, 2003, 540(1-3): 91
[16] ACHI MV, RAVINDRANATH N, DYM M.Telomere length in male germ cells is inversely correlated with telomerase activity[J]. Biol Reprod, 2000, 63(2): 591
[17] XU J, YANG X.Telomerase activity in early bovine embryos derived from parthenogenetic activation and nuclear transfer[J]. Biol Reprod, 2001, 64(3): 770
[18] 黄克智,聂大年,尹松梅,等. 白血病HL-60、HL-60A细胞Cyclin D1、hTERT表达和端粒酶活性及意义[J]. 中国实验血液学杂志,2011,19(4): 911
HUANG KZ, NIE DN, YIN SM, et al.Cyclin D1, hTERT expression and telomerase activity in HL-60 and HL-60A cell lines and their significance[J]. J Exp Hematol, 2011, 19(4):911
[19] HIROSE M, ABE-HASHIMOTO J, OGURA K, et al.A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol[J]. J Cancer Res Clin Oncol, 1997, 123(6): 337
[20] ZUO QP, LIU SK, LI ZJ, et al.NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG hepatoma cell line[J]. Eur J Pharmacol, 2011, 672(1-3): 113
[21] ZHAO X, ZHANG C, LE Z, et al.Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor related apoptosis inducing ligand induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo[J]. Int J Mol Med, 2018, 42(3): 1283
[22] 陶志华,张诗颜,陈俐丽,等. 实时荧光定量RT-PCR法检测前列腺癌组织中端粒酶hTERT mRNA表达及意义[C]//2007年浙江省医学检验学学术年会论文汇编. 2007
TAO ZH, ZHANG SY, CHEN LL, et al.Real-time fluorescence quantitative RT-PCR was used to detect telomerase hTERT mRNA expression in prostate cancer tissues and its significance[C]//2007 Zhejiang Province medical laboratory academic annual conference papers.2007
[23] LI G, SHEN J, CAO J, et al.Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461[J]. J Exp Clin Cancer Res, 2018, 37(1): 78
[24] KUMAGAI M, MIZUKOSHI E, TAMAI T, et al.Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patients[J]. Liver Int, 2018, 38(9): 1635
[25] PAVANELLO S, CARTA A, MASTRANGELO G, et al.Relationship between telomere length, genetic traits and environmental/occupational exposures in bladder cancer risk by structural equation modelling[J]. Int J Environ Res Public Health, 2017, 15(1): 5
[26] PISCUOGLIO S, NG CK, MURRAY M, et al.Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression[J]. J Pathol, 2016, 238(4): 508
[27] VAN DER KOOY D, WEISS S.Why stem cells?[J]. Science, 2000, 287(5457): 1439
[28] PITTENGER MF, MACKAY AM, BECK SC, et al.Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411): 143
[29] ZIMMERMANN S, VOSS M, KAISER S, et al.Lack of telomerase activity in human mesenchymal stem cells[J]. Leukemia, 2003, 17(6): 1146
[30] 李静远,来晓瑜,罗依,等. 人骨髓间充质干细胞端粒酶活性的表达[J]. 浙江大学学报(医学版),2004,33(6): 481
LI JY, LAI XY, LUO Y, et al.Telomerase activity of human bone marrow mesenchymal stem cells[J]. J Zhejiang Univ(Med Sci), 2004, 33(6): 492
[31] 胡宜,程鹏,刘云会. 骨髓间充质干细胞应用的风险:促瘤及成瘤性[J]. 解剖科学进展,2011,17(5): 492
HU Y, CHENG P, LIU YH.Risks in the application of bone marrow-derived mesenchymal stem cells: tumor enhancement and tumorigeness[J]. Prog Anat Sci, 2011, 17(5): 492

Options

文章导航

模态框（Modal）标题

摘要

本文引用格式

Abstract

参考文献